Natural variation of the nef gene in human immunodeficiency virus type 2 infections in Portugal

Journal of General Virology

Volumn 84, Issue 5, 2003, Pages 1287-1299

  Padua, Elizabeth ^a   Jenkins, Adrian ^b   Brown, Stuart ^b   Bootman, Janet ^b   Paixao, Maria Teresa ^a   Almond, Neil ^b   Berry, Neil ^b  

^a NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

^b NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; NEF PROTEIN; PROLINE;

ADOLESCENT; ADULT; AGED; ALLELE; AMINO ACID SUBSTITUTION; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; FISHER EXACT TEST; GENE DELETION; GENE DISRUPTION; GENE INTERACTION; GENE SEQUENCE; GENE STRUCTURE; GENETIC ANALYSIS; GENETIC CODE; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VIVO STUDY; LONG TERMINAL REPEAT; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PORTUGAL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN STRUCTURE; REVIEW; SIMIAN IMMUNODEFICIENCY VIRUS; VIRULENCE; VIRUS LOAD; VIRUS PATHOGENESIS;

ADOLESCENT; ADULT; AGED; AMINO ACID SEQUENCE; CD4 LYMPHOCYTE COUNT; CHILD; FEMALE; GENE PRODUCTS, NEF; GENES, NEF; HIV INFECTIONS; HIV-2; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PHYLOGENY; PORTUGAL; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; TERMINAL REPEAT SEQUENCES; VARIATION (GENETICS);

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; MARTES PENNANTI; RNA VIRUSES; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0037987789     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.18908-0     Document Type: Review

References (78)

1. mac251): a virus stock used for international vaccine studies. AIDS Res Hum Retroviruses 8, 77-88.
2. Andersson, S., Norrgren, H., da Silva, Z., Biague, A., Bamba, S., Kwok, S., Christopherson, C., Biberfeld, G. & Albert, J. (2000). Plasma viral load in HIV-1 and HIV-2 singly and dually infected individuals in Guinea-Bissau, West Africa: significantly lower plasma virus set point in HIV-2 infection than in HIV-1 infection. Arch Intern Med 160, 3286-3293.
3. Ariyoshi, K., Jaffar, S., Alabi, A. & 7 other authors (2000). Plasma RNA viral load predicts the rate of CD4 T cell decline and death in HIV-2-infected patients in West Africa. AIDS 14, 339-344.
4. Bell, I., Ashman, C., Maughan, J., Hooker, E., Cook, F. & Reinhart, T. A. (1998). Association of simian immunodeficiency virus Nef with the T-cell receptor (TCR) ζ chain leads to TCR down-modulation. J Gen Virol 79, 2717-2727.
5. + lymphopenia in HIV type 2-infected individuals. AIDS Res Hum Retroviruses 10, 1031-1037.
6. Berry, N. J., Ariyoshi, K., Jaffar, S., Sabally, S., Corrah, T., Tedder, R. & Whittle, H. (1998). Low peripheral blood viral HIV-2 RNA in individuals with high CD4 percentage differentiates HIV-2 from HIV-1 infection. J Hum Virol 1, 457-468.
7. Berry, N. J., Ariyoshi, K., Balfe, P., Tedder, R. & Whittle, H. (2001). Sequence specificity of the human immunodeficiency virus type 2 (HIV-2) long terminal repeat U3 region in vivo allows subtyping of the principal HIV-2 viral subtypes A and B. AIDS Res Hum Retroviruses 17, 263-267.
8. Berry, N. J., Jaffar, S., Schim van der Loeff, M. & 9 other authors (2002). Low level viremia and high CD4% predict normal survival in a cohort of HIV type 2-infected villagers. AIDS Res Hum Retroviruses 18, 1167-1173.
9. Bock, P. J. & Markovitz, D. M. (2001). Infection with HIV-2. AIDS 15 (suppl. 5), S35-S45.
10. Bonfield, J. K., Smith, K. F. & Staden, R. A. (1995). A new DNA sequence assembly program. Nucleic Acids Res 23, 4992-4999.
11. Boom, R., Sol, C. J., Salimans, M. M., Jansen, C. L., Wertheim-van Dillen, P. M. & van der Noordaa, J. (1990). Rapid and simple methods for purification of nucleic acids. J Clin Microbiol 28, 495-503.
12. Bresnahan, P. A., Yonemoto, W. & Greene, W. C. (1999). SIV Nef protein utilizes both leucine- and tyrosine-based protein sorting pathways for down-regulation of CD4. J Immunol 163, 2977-2981.
13. Carl, S., Iafrate, A. J., Lang, S., Stolte, N., Stahl-Hennig, C., Matz-Rensing, K., Fuchs, D., Skowronski, J. & Kirchhoff, F. (2000a). Simian immunodeficiency virus containing mutations in N-terminal tyrosine residues and in the PxxP motif in Nef replicates efficiently in rhesus macaques. J Virol 74, 4155-4164.
14. Carl, S., Daniels, R., Iafrate, A. J., Easterbrook, P., Greenough, T. C., Skowronski, J. & Kirchhoff, F. (2000b). Partial 'repair' of defective nef genes in a long-term nonprogressor with human immunodeficiency type 1 infection. J Infect Dis 181, 132-140.
15. Chen, Z., Luckay, A., Sodora, D. L. & 9 other authors (1997). Human immunodeficiency virus type 2 (HIV-2) seroprevalence and characterization of a distinct HIV-2 genetic subtype from the natural range of simian immunodeficiency virus-infected sooty mangabeys. J Virol 71, 3953-3960.
16. Cheng, H., Hoxie, J. & Parks, W. P. (1999). The conserved core of human immunodeficiency virus type 1 Nef is essential for association with Lck and for enhanced viral replication in T-lymphocytes. Virology 264, 5-15.
17. Clark, N. M., Hannibal, M. C. & Markovitz, D. M. (1995). The peri-κB site mediates human immunodeficiency virus type 2 enhancer activation in monocytes but not in T cells. J Virol 69, 4854-4862.
18. Clavel, F., Guetard, D., Brun-Vezinet, F. & 9 other authors (1986). Isolation of a new human retrovirus from West African patients with AIDS. Science 233, 343-346.
19. Collette, Y. (1997). Towards a consensus for a role of Nef in both viral replication and immunomodulation. Res Virol 148, 23-30.
20. Collette, Y., Dutartre, H., Benziane, A., Ramos-Morales, F., Benarous, R., Harris, M. & Olive, D. (1996). Physical and functional interaction of Nef with Lck. HIV-1 Nef-induced T-cell signaling defects J Biol Chem 71, 6333-6341.
21. Collette, Y., Arold, S., Picard, C., Janvier, K., Benichou, S., Benarous, R., Olive, D. & Dumas, C. (2000). HIV-2 and SIV Nef proteins target different Src family SH3 domains than does HIV-1 Nef because of a triple amino acid substitution. J Biol Chem 275, 4171-4176.
22. Craig, H. M., Pandori, M. W. & Guatelli, J. C. (1998). Interaction of HIV-1 Nef with the cellular dileucine-based sorting pathway is required for CD4 down-regulation and optimal viral infectivity. Proc Natl Acad Sci U S A 95, 11229-11234.
23. Deacon, N. J., Tsykin, A., Solomon, A. & other authors (1995). Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 270, 988-991.
24. Echarri, A., Gonzalez, M. E. & Carrasco, L. (1997). The N-terminal Arg-rich region of human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus Nef is involved in RNA binding. Eur J Biochem 246, 38-44.
25. Fackler, O. T. & Baur, A. S. (2002). Live and let die: Nef functions beyond HIV replication. Immunity 16, 493-497.
26. Fackler, O. T., Wolf, D., Weber, H. O. & 9 other authors (2001). A natural variability in the proline-rich motif of Nef modulates HIV-1 replication in primary T cells. Curr Biol 11, 1294-1299.
27. Felsenstein, J. (1989). Phylogenies from molecular sequences: inference and reliability. Annu Rev Genet 22, 521-565.
28. Foti, M., Mangasarian, A., Piguet, V., Lew, D. P., Krause, K.-H., Trono, D. & Carpentier, J.-L. (1997). Nef-mediated clathrin-coated pit formation. J Cell Biol 139, 37-47.
29. Gao, F., Yue, L., Robertson, D. L. & 9 other authors (1994). Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology. J Virol 68, 7433-7447.
30. Geffin, R., Wolf, D., Muller, R., Hill, M. D., Stellwag, E., Freitag, M., Sass, G., Scott, G. B. & Baur, A. S. (2000). Functional and structural defects in HIV type 1 nef genes derived from pediatric long-term survivors. AIDS Res Hum Retroviruses 16, 1855-1868.
31. Geleziunas, R., Xu, W., Takeda, K., Ichijo, H. & Greene, W. C. (2001). HIV-1 Nef inhibits ASK1-dependent death signalling providing a potential mechanism for protecting the infected host cell. Nature 410, 834-838.
32. Geyer, M., Fackler, O. T. & Peterlin, B. M. (2001). Structure-function relationships in HIV-1 Nef. EMBO Rep 21, 580-585.
33. Grassly, N. C., Xiang, Z., Ariyoshi, K., Aaby, P., Jensen, H., van der Loeff, M. S., Dias, F., Whittle, H. & Breuer, J. (1998). Mortality among human immunodeficiency virus type 2-positive villagers in rural Guinea-Bissau is correlated with viral genotype. J Virol 72, 7895-7899.
34. Greenberg, M. E., Bronson, S., Lock, M., Neumann, M., Pavlakils, G. N. & Skowronski, J. (1997). Co-localization of HIV-1 Nef with the AP-2 adaptor protein complex correlates with Nef-induced CD4 down-regulation. EMBO J 16, 6964-6976.
35. Greenway, A. L., Dutartre, H., Allen, K., McPhee, D. A., Olive, D. & Collette, Y. (1999). Simian immunodeficiency virus and human immunodeficiency virus type 1 Nef protein show distinct patterns and mechanisms of Src kinase activation. J Virol 73, 6152-6158.
36. Hanna, Z., Kay, D. G., Rebai, N., Guimond, A., Jothy, S. & Jolicoeur, P. (1998). Nef harbours a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice. Cell 95, 163-175.
37. Hanna, Z., Wang, X., Kay, D. G., Poudrier, J., Lowell, C. & Jolicoeur, P. (2001). The pathogenicity of human immunodeficiency virus (HIV) type 1 Nef in CD4C/HIV transgenic mice is abolished by mutation of its SH3-binding domain, and disease development is delayed in the absence of Hck. J Virol 75, 9378-9392.
38. Harris, M. (1995). The role of myristoylation in the interactions between the human immunodeficiency virus type 1 Nef and cellular proteins. Biochem Soc Trans 23, 557-561.
39. Jubler-Maurin, V., Saragosti, S., Perret, J.-L. & 7 other authors (1999). Genetic characterization of the nef gene from human immunodeficiency virus type 1 group M strains representing genetic subtypes A, B, C, E, F, G, and H. AIDS Res Hum Retroviruses 15, 23-32.
40. Karn, T., Hock, B., Holtrich, U., Adamski, M., Strebhardt, K. & Rubsamen-Waigmann, H. (1998). Nef proteins of distinct HIV-1 or -2 isolates differ in their binding properties for HCK: isolation of a novel Nef binding factor with characteristics of an adaptor protein. Virology 246, 45-52.
41. Kestler, H. W., III Ringler, D. J., Mori, K., Panicali, D. L., Sehgai, P. K., Daniel, M. D. & Desrosiers, R. C. (1991). Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65, 651-662.
42. Khan, I. H., Sawai, E. T., Antonio, E., Weber, C. J., Mandell, C. P., Montbriand, P. & Luciw, P. A. (1998). Role of the SH3-ligand domain of simian immunodeficiency virus Nef in interaction with Nef-associated kinase and simian AIDS in rhesus macaques. J Virol 72, 5820-5830.
43. Kirchhoff, F., Easterbrook, P. J., Douglas, N., Troop, M., Greenough, T. C., Weber, J., Carl, S., Sullivan, J. L. & Daniels, R. S. (1999). Sequence variations in human immunodeficiency virus type 1 Nef are associated with different stages of disease. J Virol 73, 5497-5508.
44. Lang, S. M., Iafrate, A. J., Stahl-Hennig, C. & 7 other authors (1997). Association of simian immunodeficiency virus Nef with cellular serine/threonine kinases is dispensable for the development of AIDS in rhesus macaques. Nat Med 3, 860-865.
45. Learmont, J. C., Geczy, A. F., Mills, J. & 9 other authors (1999). Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1. N Engl J Med 340, 1715-1722.
46. Lee, C.-H., Leung, B., Lemmon, M. A., Zheng, J., Cowburn, D., Kuriyan, J. & Saksela, K. (1995). A single amino acid in the SH3 domain of Hck determines its high affinity and specificity in binding to HIV-1 Nef protein. EMBO J 14, 5006-5015.
47. Leiden, J. R., Wang, C.-Y., Petryniak, B., Markovitz, D. M., Nabel, G. J. & Thompson, C. B. (1992). A novel Ets-related transcription factor, Elf-1, binds to human immunodeficiency virus type 2 regulatory elements that are required for inducible trans activation in T cells. J Virol 66, 5890-5897.
48. Lock, M., Greenberg, M. E., Iafrate, A. J., Swigut, T., Muench, J., Kirchhoff, F., Shohdy, N. & Skowronski, J. (1999). Two elements target SIV Nef to the AP-2 clathrin adaptor complex, but only one is required for the induction of CD4 endocytosis. EMBO J 18, 2722-2733.
49. Luo, W. & Peterlin, M. (1997). Activation of the T-cell receptor signaling pathway by Nef from an aggressive strain of simian immunodeficiency virus. J Virol 71, 9531-9537.
50. Mangasarian, A., Piguet, V., Wang, J.-K., Chen, Y.-L. & Trono, D. (1999). Nef-induced CD4 and major histocompatibility complex class I (MHC-I) down-regulation are governed by distinct determinants: N-terminal α helix and proline repeat of Nef selectively regulate MHC-I trafficking. J Virol 73, 1964-1973.
51. Manninen, A., Hiipakka, M., Vihinen, M., Lu, W., Mayer, B. J. & Saksela, K. (1998). SH3-domain binding function of HIV-1 Nef is required for association with a PAK-related kinase. Virology 250, 273-282.
52. Markovitz, D., Smith, M., Hilfinger, J., Hannibal, M. C., Petryniak, B. & Nabel, G. J. (1992). Activation of the human immunodeficiency virus type 2 enhancer is dependent on purine box and κB regulatory elements. J Virol 66, 5479-5484.
53. Marlink, R., Kanki, P., Thior, I. & other authors (1994). Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science 265, 1587-1590.
54. Michael, N. L., Chang, G., d'Arcy, L., Ehrenberg, P. K., Mariani, R., Busch, M. P., Birx, D. L. & Schwartz, D. H. (1995). Defective accessory genes in a human immunodeficiency virus type-1-infected long-term survivor lacking recoverable virus. J Virol 69, 4228-4236.
55. 2 microglobulin concentration and disease evolution. J Infect Dis 181, 64-75.
56. Mourich, D. V., Lee, S., Reyes-Teran, G., Mackewicz, C. E. & Levy, J. A. 1999). Lack of differences in nef alleles among HIV-infected asymptomatic long-term survivors and those who progressed to disease. AIDS Res Hum Retroviruses 15, 1573-1575.
57. National AIDS Commission (2002). HIV/AIDS infection, situation in Portugal at 30 June 2002, doc. 128. National Institute of Health, Lisbon, Portugal: CVEDT.
58. Pieniazek, D., Ellenberger, D., Janini, L. M. & 11 other authors (1999). Predominance of human immunodeficiency virus type 2 subtype B in Abidjan, Ivory Coast. AIDS Res Hum Retroviruses 15, 603-608.
59. Piguet, V. & Trono, D. (1999). The Nef protein of primate lentiviruses. Rev Med Virol 9, 111-120.
60. Piguet, V., Chen, Y.-L., Mangasarian, A., Foti, M., Carpentier, J.-L. & Trono, D. (1998). Mechanisms of Nef-induced CD4 endocytosis: Nef connects CD4 with the mu chain of adaptor complexes. EMBO J 17, 2472-2481.
61. Piguet, V., Gu, F., Foti, M., Demaurex, N., Gruenberg, J., Carpentier, J.-L. & Trono, D. (1999). Nef-induced CD4 degradation: a diacidic-based motif in Nef functions as a lysosomal targeting signal through the binding of β-COP in endosomes. Cell 97, 63-73.
62. Popper, S. J., Sarr, A. D., Travers, K. U., Gueye-Ndiaye, A., Mboup, S., Essex, M. E. & Kanki, P. J. (1999). Lower human immunodeficiency (HIV) type 2 viral load reflects the difference in pathogenicity of HIV-1 and HIV-2. J Infect Dis 180, 1116-1121.
63. Poulsen, A. G., Aaby, P., Larsen, O., Jensen, H., Naucler, A., Lisse, I. M., Christiansen, C. B., Dias, F. & Melbye, M. (1997). 9-year HIV-2-associated mortality in an urban community in Bissau, west Africa. Lancet 349, 911-914.
64. Reeves, J. D. & Doms, R. W. (2002). Human immunodeficiency virus type 2. J Gen Virol 83, 1253-1265.
65. Saksela, K., Cheng, G. & Baltimore, D. (1995). Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not for down-regulation of CD4. EMBO J 14, 484-491.
66. Schim van der Loeff, M. F. & Aaby, P. (1999). Towards a better understanding of the epidemiology of HIV-2. AIDS 13 (suppl. A), S69-S84.
67. Schulz, T. F., Whitby, D., Hoad, J. G., Corrah, T., Whittle, H. & Weiss, R. A. (1990). Biological and molecular variability of human immunodeficiency virus type 2 isolates from The Gambia. J Virol 64, 5177-5182.
68. Shankarappa, R., Margolick, J. B., Gange, S. J. & 9 other authors (1999). Consistence viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J Virol 73, 10489-10502.
69. Simmons, A., Aluvihare, V. & McMichael, A. (2001). Nef triggers a transcriptional program in T cells imitating single-signal T cell activation and inducing HIV virulence mediators. Immunity 14, 763-777.
70. Simon, F., Matheron, S., Tamalet, C. & 9 other authors (1993). Cellular and plasma viral load in patients infected with HIV-2. AIDS 7, 1411-1417.
71. Soriano, V., Gomes, P., Heneine, W. & 10 other authors (2000). Human immunodeficiency virus type 2 (HIV-2) in Portugal: clinical spectrum, circulating subtypes, virus isolation and plasma viral load. J Med Virol 61, 111-116.
72. Switzer, W. M., Wiktor, S., Soriano, V. & 7 other authors (1998). Evidence of Net truncation in human immunodeficiency virus type 2 infection. J Infect Dis 177, 65-71.
73. Thompson, J. D., Higgins, D. G. & Gibson, T. J. (1994). CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22, 4673-4680.
74. Whatmore, A. M., Cook, N., Hall, G. A., Sharpe, S., Rud, E. W. & Cranage, M. P. (1995). Repair and evolution of nef in vivo modulates simian immunodeficiency virus virulence. J Virol 69, 5117-5123.
75. Whittle, H. A., Morris, J., Todd, J., Corrah, T., Sabally, S., Bangali, J., N'Gom, P. T., Rolfe, M. & Wilkins, A. (1994). HIV-2-infected patients survive longer than HIV-1-infected patients. AIDS 8, 1617-1620.
76. Whittle, H. C., Ariyoshi, K. & Rowland-Jones, S. (1998). HIV-2 and T cell recognition. Curr Opin Immunol 10, 382-387.
77. Wolf, D., Witte, V., Laffert, B., Blume, K., Stromer, E., Trapp, S., d'Aloja, P., Schurmann, A. & Baur, A. S. (2001). HIV-1 Nef associated PAK and P13-kinases stimulate Akt-independent Bad-phosphorylation to induce anti-apoptotic signals. Nat Med 7, 1217-1224.
78. Yamaguchi, J., Devare, S. G. & Brennan, C. (2000). Identification of a new HIV-2 subtype based on phylogenetic analysis of full-length genomic sequence. AIDS Res Hum Retroviruses 9, 925-930.